29 related articles for article (PubMed ID: 34358376)
1. The inhibitors of KDM4 and KDM6 histone lysine demethylases enhance the anti-growth effects of erlotinib and HS-173 in head and neck cancer cells.
Kleszcz R; Skalski M; Krajka-Kuźniak V; Paluszczak J
Eur J Pharm Sci; 2021 Nov; 166():105961. PubMed ID: 34363938
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of β-Catenin Inhibition of Axitinib and Nitazoxanide in Human Monocyte-Derived Dendritic Cells.
Azeem W; Bakke RM; Gabriel B; Appel S; Øyan AM; Kalland KH
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440153
[TBL] [Abstract][Full Text] [Related]
3. Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway.
Lin QY; Qi QL; Hou S; Chen Z; Jiang N; Zhang L; Lin CH
Neoplasma; 2021 Sep; 68(5):1063-1071. PubMed ID: 34374294
[TBL] [Abstract][Full Text] [Related]
4. Dietary citrate acutely induces insulin resistance and markers of liver inflammation in mice.
Branco JR; Esteves AM; Leandro JGB; Demaria TM; Godoi V; Marette A; Valença HDM; Lanzetti M; Peyot ML; Farfari S; Prentki M; Zancan P; Sola-Penna M
J Nutr Biochem; 2021 Dec; 98():108834. PubMed ID: 34371126
[TBL] [Abstract][Full Text] [Related]
5. Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer-A Step before Anakoinosis-Based Personalized Treatment.
Kleszcz R
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686523
[TBL] [Abstract][Full Text] [Related]
6. Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells.
Kleszcz R; Frąckowiak M; Dorna D; Paluszczak J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445628
[TBL] [Abstract][Full Text] [Related]
7. PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.
Marquard FE; Jücker M
Biochem Pharmacol; 2020 Feb; 172():113729. PubMed ID: 31785230
[TBL] [Abstract][Full Text] [Related]
8. The Significance of the Dysregulation of Canonical Wnt Signaling in Head and Neck Squamous Cell Carcinomas.
Paluszczak J
Cells; 2020 Mar; 9(3):. PubMed ID: 32183420
[TBL] [Abstract][Full Text] [Related]
9. The combinatorial inhibition of Wnt signaling and Akt kinase is beneficial for reducing the survival and glycolytic activity of tongue cancer cells.
Kleszcz R; Paluszczak J
J Oral Pathol Med; 2022 Mar; 51(3):231-239. PubMed ID: 34358376
[TBL] [Abstract][Full Text] [Related]
10. The Wnt Signaling Pathway Inhibitors Improve the Therapeutic Activity of Glycolysis Modulators against Tongue Cancer Cells.
Kleszcz R; Paluszczak J
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163171
[TBL] [Abstract][Full Text] [Related]
11. PRI-724 and IWP-O1 Wnt Signaling Pathway Inhibitors Modulate the Expression of Glycolytic Enzymes in Tongue Cancer Cell Lines.
Kleszcz R; Paluszczak J; Belka M; Krajka-Kuźniak V
Curr Issues Mol Biol; 2023 Nov; 45(12):9579-9592. PubMed ID: 38132445
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
